Cost-effectiveness of hospital-based treatment compared with community treatment centres: an analysis of Korea National Health Insurance claims data

被引:0
|
作者
Lee, Jeongeun [1 ]
Lee, Donghyun [2 ]
Kwon, Ohtak [1 ]
机构
[1] Hlth Insurance Review & Assessment Serv, Seoul, South Korea
[2] Yonsei Univ, Seoul, South Korea
来源
BMJ OPEN | 2024年 / 14卷 / 07期
关键词
COVID-19; infection control; health policy;
D O I
10.1136/bmjopen-2023-079232
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives We compared the cost-effectiveness of hospital-based treatment and that of community treatment centres (CTCs).Design We performed statistical analysis to compare the expenses incurred by COVID-19 patients who received hospital care with those incurred by COVID-19 patients who went to CTCs.Setting and participants A study was conducted on 411 530 COVID-19 inpatients and 243 329 CTC patients from January 2020 to December 2021.Main outcome measures We calculated the probability of severe disease, hospitalisation period and medical expenses for inpatients and CTC patients. Subsequently, we analysed the cost-effectiveness of CTC compared with hospitalisation.Results Comparing medical expenses, CTC patients incurred 2 220 000 KRW on average, which is less than the expenses incurred by hospitalised COVID-19 patients.Conclusions The study suggests that using a CTC may be more cost-effective than a hospital service alone.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Nationwide incidence and treatment pattern of retinopathy of prematurity in South Korea using the 2007-2018 national health insurance claims data
    Hong, Eun Hee
    Shin, Yong Un
    Bae, Gi Hwan
    Choi, Young Jin
    Ahn, Seong Joon
    Sobrin, Lucia
    Hong, Rimkyung
    Kim, Inah
    Cho, Heeyoon
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [42] EFFECT OF THE CHANGE IN COST-EFFECTIVENESS THRESHOLD ON THE NEWLY LISTED ANTICANCER DRUG PRICES IN THE NATIONAL HEALTH INSURANCE OF SOUTH KOREA
    Choi, S. E.
    Basu, A.
    VALUE IN HEALTH, 2019, 22 : S490 - S490
  • [43] Cost and cost-effectiveness of community based and health facility based directly observed treatment of tuberculosis in Dar es Salaam, Tanzania
    Wandwalo E.
    Robberstad B.
    Morkve O.
    Cost Effectiveness and Resource Allocation, 3 (1)
  • [44] Implementing quality indicators using health insurance claims data linked to the hospital-based cancer registry.
    Nakamura, Fumiaki
    Masuda, Masato
    Teramoto, Norihiro
    Mizumoto, Kazuhiro
    Mekata, Eiji
    Higashide, Shunichi
    Ohtani, Mikinobu
    Higashi, Takahiro
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (31)
  • [45] Cost-effectiveness analysis of letrozole compared to tamoxifen for treatment of early breast cancer in the Hungarian health care setting
    Kosa, J.
    VALUE IN HEALTH, 2006, 9 (06) : A281 - A282
  • [46] Cost-effectiveness analysis of the national decentralization policy of antiretroviral treatment programme in Zambia
    Miyano, Shinsuke
    Syakantu, Gardner
    Komada, Kenichi
    Endo, Hiroyoshi
    Sugishita, Tomohiko
    COST EFFECTIVENESS AND RESOURCE ALLOCATION, 2017, 15
  • [47] Cost-effectiveness analysis of the national decentralization policy of antiretroviral treatment programme in Zambia
    Shinsuke Miyano
    Gardner Syakantu
    Kenichi Komada
    Hiroyoshi Endo
    Tomohiko Sugishita
    Cost Effectiveness and Resource Allocation, 15
  • [48] COST-EFFECTIVENESS OF RADICAL PROSTATECTOMY, RADIATION THERAPY AND ACTIVE SURVEILLANCE FOR THE TREATMENT OF LOCALIZED PROSTATE CANCER - A CLAIMS DATA ANALYSIS
    Brandes, A.
    Koerber, F.
    Schwarzkopf, L.
    Hunger, M.
    Waidelich, R.
    Rogowski, W.
    VALUE IN HEALTH, 2014, 17 (07) : A636 - A637
  • [49] Cost and cost-effectiveness of tuberculosis treatment shortening: a model-based analysis
    G. B. Gomez
    D. W. Dowdy
    M. L. Bastos
    A. Zwerling
    S. Sweeney
    N. Foster
    A. Trajman
    M. A. Islam
    S. Kapiga
    E. Sinanovic
    G. M. Knight
    R. G. White
    W. A. Wells
    F. G. Cobelens
    A. Vassall
    BMC Infectious Diseases, 16
  • [50] Cost and cost-effectiveness of tuberculosis treatment shortening: a model-based analysis
    Gomez, G. B.
    Dowdy, D. W.
    Bastos, M. L.
    Zwerling, A.
    Sweeney, S.
    Foster, N.
    Trajman, A.
    Islam, M. A.
    Kapiga, S.
    Sinanovic, E.
    Knight, G. M.
    White, R. G.
    Wells, W. A.
    Cobelens, F. G.
    Vassall, A.
    BMC INFECTIOUS DISEASES, 2016, 16